Product Details
Trulicity 1.5 Mg/0.5 ML Pen
Manufacturer: Eli Lilly
MFG#: 00002-1434-80
NDC: 00002-1434-80
PID: 644180
4/EA
$1,736.96
In StockAdditional Information
| Product Name | Trulicity 1.5 Mg/0.5 Ml Pen |
| Application | Incretin Mimetic for Type 2 Diabetes |
| Generic Drug Name | Dulaglutide |
| Mechanism of Action | GLP-1 receptor agonist that enhances insulin secretion and suppresses glucagon release |
| Strength | 1.5 mg / 0.5 mL |
| Type | Subcutaneous Injection |
| Administration | Once weekly via subcutaneous injection |
| Common Side Effects | Nausea, vomiting, diarrhea, abdominal pain |
| Serious Side Effects | Risk of pancreatitis, thyroid C-cell tumors |
| Drug Interactions | May require dose adjustments with insulin or sulfonylureas to reduce hypoglycemia risk |
| Special Precautions | Use with caution in patients with gastrointestinal disorders |
| Storage Requirements | Requires Refrigeration (2°C to 8°C) |
| Quantity | 4 Pens |
| Container Type | Prefilled Injection Pen |
| Primary Use | Improves glycemic control in adults with type 2 diabetes |
Description
Trulicity 1.5 mg/0.5 mL is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the management of type 2 diabetes mellitus. It enhances glycemic control by stimulating insulin secretion in response to elevated blood glucose levels. The medication also suppresses glucagon secretion, which helps reduce hepatic glucose production. It is not intended for use in patients with type 1 diabetes or diabetic ketoacidosis.
The prefilled, single-dose pens contain dulaglutide, which is administered via subcutaneous injection once weekly. The formulation ensures consistent absorption, providing prolonged glucose control. The pen design facilitates self-administration, reducing the complexity of diabetes management. Trulicity is commonly prescribed in conjunction with diet and exercise to improve blood sugar levels.
Trulicity has demonstrated efficacy in lowering HbA1c levels and promoting weight loss in some patients. The medication may cause gastrointestinal side effects, including nausea, vomiting, and diarrhea, particularly at the start of therapy. Hypoglycemia risk increases when combined with other glucose-lowering agents such as insulin or sulfonylureas.
Frequently Asked Questions (FAQs)
The cost of Trulicity 1.5 Mg/0.5 ML Pen is $$1,736.96
Trulicity 1.5 Mg/0.5 ML Pen is manufactured by Eli Lilly.
You can purchase Trulicity 1.5 Mg/0.5 ML Pen on our website at https://supplies.pipelinemedical.com/product/detail/trulicity-1-5-mg-0-5-ml-pen-350875